Changes of plasma brain-derived neurotrophic factor in patients with bipolar disorder type I

Journal of Shanghai Jiaotong University (Medical Science)

Volumn 31, Issue 11, 2011, Pages 1532-1535

  Wang, Zuo Wei ^a,b   Li, Ze Zhi ^a   Lin, Zhi Guang ^a   Wu, Zhi Guo ^a   Yuan, Cheng Mei ^a   Hong, Wu ^a   Li, Chun Bo ^a   Fang, Yi Ru ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Mental Health Centre of Hongkou District   (China)

Author keywords

Bipolar disorder; Brain derived neurotrophic factor; Manic episode; Plasma

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; LITHIUM; QUETIAPINE;

BIPOLAR I DISORDER; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; HUMAN; PROTEIN BLOOD LEVEL; REVIEW; YOUNG MANIA RATING SCALE;

EID: 83155183980     PISSN: 16748115     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1674-8115.2011.11.006     Document Type: Review

References (12)

1. Zhou R, Yuan P, Wang Y, et al. Evidence for selective microRNAs and their effectors as common long-term targets for the actions of mood stabilizers [J]. Neuropsychopharmacology, 2009, 34 (6): 1395-1405.
2. Chinese source.
3. Kim HW, Rapoport SI, Rao JS. Altered expression of apoptotic factors and synaptic markers in postmortem brain from bipolar disorder patients[J]. Neurobiol Dis, 2010, 37 (3): 596-603.
4. Park SW, Lee SK, Kim JM, et al. Effects of quetiapine on the brain-derived neurotrophic factor expression in the hippocampus and neocortex of rats[J]. Neurosci Lett, 2006, 402(1-2): 25-29.
5. Hammonds MD, Shim SS. Effects of 4-week treatment with lithium and olanzapine on levels of brain-derived neurotrophic factor, B-cell CLL/lymphoma 2 and phosphorylated cyclic adenosine monophosphate response element-binding protein in the sub-regions of the hippocampus[J]. Basic Clin Pharmacol Toxicol, 2009, 105(2): 113-119.
6. Chang YC, Rapoport SI, Rao JS. Chronic administration of mood stabilizers upregulates BDNF and bcl-2 expression levels in rat frontal cortex[J]. Neurochem Res, 2009, 34(3): 536-541.
7. Klein AB, Williamson R, Santini MA, et al. Blood BDNF concentrations reflect brain-tissue BDNF levels across species [J]. Int J Neuropsychopharmacol, 2010, 14(3): 347-353.
8. Lin PY. State-dependent decrease in levels of brain-derived neurotrophic factor in bipolar disorder: a meta-analytic study [J]. Neurosci Lett, 2009, 466(3): 139-143.
9. Barbosa IG, Huguet RB, Mendonya VA, et al. Increased plasma levels of brain-derived neurotrophic factor in patients with long-term bipolar disorder[J]. Neurosci Lett, 2010, 475(2): 95-98.
10. Eisch AJ, Bolaños CA, de Wit J, et al. Brain-derived neurotrophic factor in the ventral midbrain-nucleus accumbens pathway: a role in depression[J]. Biol Psychiatry, 2003, 54(10): 994-1005.
11. Kauer-Sant'Anna M, Kapczinski F, Andreazza AC, et al. Brain-de-rived neurotrophic factor and inflammatory markers in patients with early-vs. late-stage bipolar disorder[J]. Int J Neuropsychopharmacol, 2009, 12(4): 447-458.
12. Eckert GP, Schaeffer EL, Schmitt A, et al. Increased brain membrane fluidity in schizophrenia[J]. Pharmacopsychiatry, 2011, 44 (4): 161-162.